AR240018A1
(es)
*
|
1987-10-07 |
1990-01-31 |
Merrell Pharma Inc |
Procedimiento para preparar una composicion que comprende derivados de piperidinoalcanol.
|
US4929605A
(en)
*
|
1987-10-07 |
1990-05-29 |
Merrell Dow Pharmaceuticals Inc. |
Pharmaceutical composition for piperidinoalkanol derivatives
|
CN1053570C
(zh)
|
1987-10-07 |
2000-06-21 |
默尔多药物公司 |
哌啶子基链烷醇的药用组合物-减充血剂复方的制备方法
|
US4908372A
(en)
*
|
1988-10-13 |
1990-03-13 |
Merrell Dow Pharmaceuticals Inc. |
Antihistaminic piperidinyl benzimidazoles
|
ZA90341B
(en)
*
|
1989-01-23 |
1990-10-31 |
Merrell Dow Pharma |
Liquid pharmaceutical composition for piperidinoalkanol derivatives
|
DE3917241A1
(de)
*
|
1989-05-26 |
1990-11-29 |
Schaper & Bruemmer Gmbh |
4-(hydroxydiphenylmethyl)-1-piperidyl-phenylalkan-derivate
|
US5182097A
(en)
*
|
1991-02-14 |
1993-01-26 |
Virginia Commonwealth University |
Formulations for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
|
US5190029A
(en)
*
|
1991-02-14 |
1993-03-02 |
Virginia Commonwealth University |
Formulation for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
|
TW198008B
(fr)
*
|
1991-04-08 |
1993-01-11 |
Green Cross Corp |
|
HU211019B
(en)
*
|
1991-12-02 |
1995-09-28 |
Richter Gedeon Vegyeszet |
Process for producing new 1,2,3,6-tetrahydropyridine and piperidine derivatives substituted with n-(hydroxylalkyl) group and compositions comprising such compounds
|
NZ249286A
(en)
*
|
1992-02-13 |
1996-02-27 |
Merrell Dow Pharma |
Piperidine-4-ylmethyl thiophene and thiazole derivatives and pharmaceutical compositions
|
ES2176201T3
(es)
*
|
1992-04-10 |
2002-12-01 |
Merrell Pharma Inc |
Derivados de 4-difenilmetil piperidina y procedimiento de preparacion.
|
US5631375A
(en)
*
|
1992-04-10 |
1997-05-20 |
Merrell Pharmaceuticals, Inc. |
Process for piperidine derivatives
|
AU679910B2
(en)
|
1992-05-11 |
1997-07-17 |
Merrell Pharmaceuticals Inc. |
Use of terfenadine derivatives as antihistaminics in a hepatically impaired patient
|
GB2284351B
(en)
*
|
1992-08-03 |
1996-11-27 |
Sepracor Inc |
Terfenadine metabolites and their optically pure isomers for treating allergic disorders
|
US5654433A
(en)
*
|
1993-01-26 |
1997-08-05 |
Merrell Pharmaceuticals Inc. |
Process for piperidine derivatives
|
US20020007068A1
(en)
|
1999-07-16 |
2002-01-17 |
D'ambra Thomas E. |
Piperidine derivatives and process for their production
|
DE69415319T2
(de)
*
|
1993-06-24 |
1999-06-10 |
Albany Molecular Research, Inc., Albany, N.Y. |
Verfahren zur herstellung von piperidinderivaten
|
CA2362337C
(fr)
*
|
1993-06-25 |
2005-08-02 |
Merrell Pharmaceuticals Inc. |
Nouveaux intermediaires pour la preparation de derives de 4-diphenylmethyl/diphenylmethoxy piperidine, antihistaminiques
|
US6147216A
(en)
*
|
1993-06-25 |
2000-11-14 |
Merrell Pharmaceuticals Inc. |
Intermediates useful for the preparation of antihistaminic piperidine derivatives
|
WO1995010278A1
(fr)
*
|
1993-10-15 |
1995-04-20 |
Hoechst Marion Roussel, Inc. |
Traitement des troubles allergiques par le carboxylate de terfenadine
|
JPH09509138A
(ja)
*
|
1993-10-25 |
1997-09-16 |
メレルファーマスーティカルズ インコーポレイテッド |
ターフェナジン及びイブプロフェンの安定な製剤組成物
|
NZ284277A
(en)
*
|
1994-05-16 |
1998-01-26 |
Merrell Pharma Inc |
Optical resolution of racemic alpha-[4-(1,1-dimethylethyl)phenyl]-4-(hydroxydiphenylmethyl)-1 -piperidinebutanol derivatives
|
CN101497581B
(zh)
*
|
1994-05-18 |
2012-07-11 |
安万特萨博Ⅱ有限公司 |
抗组胺哌啶衍生物,其多晶形物和假同晶物的无水和水合物形式的制备方法
|
US20030045722A1
(en)
*
|
1994-05-18 |
2003-03-06 |
Henton Daniel R. |
Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
|
CN1907967B
(zh)
*
|
1994-05-18 |
2012-07-04 |
安万特萨博Ⅱ有限公司 |
抗组胺哌啶衍生物,其多晶形物和假同晶物的无水和水合物形式的制备方法
|
ES2132709T3
(es)
|
1994-08-25 |
1999-08-16 |
Merrell Pharma Inc |
Nuevas piperidinas substituidas utiles para el tratamiento de las enfermedades alergicas.
|
HUP9802086A3
(en)
*
|
1995-02-28 |
2001-02-28 |
Aventis Pharmaceuticals Inc Br |
Pharmaceutical composition for piperidinoalkanol compounds
|
CA2216877A1
(fr)
*
|
1995-05-08 |
1996-11-14 |
Hoechst Marion Roussel, Inc. |
Derives butanol d'alpha-(alkylphenyl substitue)-4-(hydroxydiphenylmethyl)-1-piperidine, leur preparation et leur utilisation en tant qu'agents antihistaminiques, antiallergiques et dilatateurs bronchiques
|
US5574045A
(en)
*
|
1995-06-06 |
1996-11-12 |
Hoechst Marion Roussel, Inc. |
Oral pharmaceutical composition of piperidinoalkanol compounds in solution form
|
US5906747A
(en)
*
|
1995-11-13 |
1999-05-25 |
Biosepra Inc. |
Separation of molecules from dilute solutions using composite chromatography media having high dynamic sorptive capacity at high flow rates
|
US6211199B1
(en)
|
1995-11-17 |
2001-04-03 |
Aventis Pharmaceuticals Inc. |
Substituted 4-(1H-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases
|
US6194406B1
(en)
|
1995-12-20 |
2001-02-27 |
Aventis Pharmaceuticals Inc. |
Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic disease
|
US6423704B2
(en)
|
1995-12-20 |
2002-07-23 |
Aventis Pharmaceuticals Inc. |
Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic diseases
|
US6153754A
(en)
|
1995-12-21 |
2000-11-28 |
Albany Molecular Research, Inc. |
Process for production of piperidine derivatives
|
US6201124B1
(en)
|
1995-12-21 |
2001-03-13 |
Albany Molecular Research, Inc. |
Process for production of piperidine derivatives
|
US5998439A
(en)
|
1996-02-21 |
1999-12-07 |
Hoescht Marion Roussel, Inc. |
Substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
|
US5932571A
(en)
*
|
1996-02-21 |
1999-08-03 |
Hoechst Marion Roussel, Inc. |
Substituted N-methyl-N-(4-(4-(1H-benzimidazol-2-yl) {1,4}diazepan-1-yl)-2-(aryl) butyl) benzamides useful for the treatment of allergic diseases
|
US5922737A
(en)
*
|
1996-02-21 |
1999-07-13 |
Hoechst Marion Roussel, Inc. |
Substituted N-methyl-N-(4-(4-(1H-Benzimidazol-2-YL-amino) piperidin-1-YL)-2-(arlyl) butyl) benzamides useful for the treatment of allergic diseases
|
US5925761A
(en)
*
|
1997-02-04 |
1999-07-20 |
Sepracor Inc. |
Synthesis of terfenadine and derivatives
|
ATE260983T1
(de)
*
|
1997-03-11 |
2004-03-15 |
Aventis Pharma Inc |
Verfahren zur herstellung von 4-(4-(4- (hydroxydiphenyl)-1-piperidinyl)-1-hydroxybutyl - alpha,alpha-dimenthylphenylessigsäure und phosphorylierter derivate
|
US6451815B1
(en)
|
1997-08-14 |
2002-09-17 |
Aventis Pharmaceuticals Inc. |
Method of enhancing bioavailability of fexofenadine and its derivatives
|
ID22891A
(id)
*
|
1997-08-26 |
1999-12-16 |
Hoechst Marion Roussel Inc |
Komposisi farmasi untuk kombinasi piperidinoalkanol-dekongestan
|
ATE243191T1
(de)
*
|
1997-12-17 |
2003-07-15 |
Aventis Pharma Gmbh |
Verfahren zur alkylierung von alkyl- oder benzylcyanderivaten in gegenwart von trialkylaminen oder -phosphinen
|
CZ301349B6
(cs)
*
|
1997-12-23 |
2010-01-27 |
Schering Corporation |
Prostredek k lécbe respiracních a kožních onemocnení, který obsahuje alespon jednoho antagonistu leukotrienu a alespon jedno antihistaminikum
|
US6194431B1
(en)
*
|
1998-04-14 |
2001-02-27 |
Paul D. Rubin |
Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors
|
US6683094B2
(en)
|
1998-07-02 |
2004-01-27 |
Aventis Pharmaceuticals Inc. |
Antihistaminic piperidine derivatives and intermediates for the preparation thereof
|
US6673933B2
(en)
|
1998-07-02 |
2004-01-06 |
Aventis Pharmaceutical Inc. |
Antihistaminic piperidine derivatives and intermediates for the preparation thereof
|
AU2007200674C1
(en)
*
|
1998-07-02 |
2011-02-24 |
Aventisub Llc |
Novel antihistaminic piperidine derivatives and intermediates for the preparation thereof
|
JP2002519411A
(ja)
*
|
1998-07-02 |
2002-07-02 |
アベンティス・ファーマスーティカルズ・インコーポレイテツド |
新規な抗ヒスタミン性ピペリジン誘導体およびその製造のための中間体
|
GB9822170D0
(en)
*
|
1998-10-13 |
1998-12-02 |
Danbioyst Uk Ltd |
Novel formulations of fexofenadine
|
IN191492B
(fr)
*
|
1999-05-25 |
2003-12-06 |
Ranbaxy Lab Ltd |
|
US6613906B1
(en)
*
|
2000-06-06 |
2003-09-02 |
Geneva Pharmaceuticals, Inc. |
Crystal modification
|
US6613907B2
(en)
|
2000-11-08 |
2003-09-02 |
Amr Technology, Inc. |
Process for the production of piperidine derivatives with microorganisms
|
CH695216A5
(de)
*
|
2001-02-23 |
2006-01-31 |
Cilag Ag |
Verfahren zur Herstellung eines nicht hydratisierten Salzes eines Piperidinderivats und eine so erhältliche neue kristalline Form eines solchen Salzes.
|
KR20040012747A
(ko)
*
|
2001-04-09 |
2004-02-11 |
테바 파마슈티컬 인더스트리즈 리미티드 |
펙소페나딘 염산염의 다형체
|
US20030021849A1
(en)
*
|
2001-04-09 |
2003-01-30 |
Ben-Zion Dolitzky |
Polymorphs of fexofenadine hydrochloride
|
US7700779B2
(en)
*
|
2001-06-18 |
2010-04-20 |
Dr. Reddy's Laboratories Limited |
Crystalline forms of fexofenadine and its hydrochloride
|
EP1399422A2
(fr)
|
2001-06-18 |
2004-03-24 |
Dr. Reddy's Laboratories Ltd. |
Nouvelles formes cristallines d'acide 4- 4- 4-(hydroxydiphenylmethyl)-1-piperindinyl]-1-hydroxybutyl-a,a- dimethylbenzene acetique et son chlorhydrate
|
WO2003039482A2
(fr)
*
|
2001-11-08 |
2003-05-15 |
Teva Pharmaceutical Industries Ltd. |
Polymorphes a base fexofenadine
|
US20030158227A1
(en)
*
|
2001-11-08 |
2003-08-21 |
Barnaba Krochmal |
Polymorphs of fexofenadine base
|
US6723348B2
(en)
*
|
2001-11-16 |
2004-04-20 |
Ethypharm |
Orodispersible tablets containing fexofenadine
|
AU2003217676B2
(en)
|
2002-02-22 |
2009-06-11 |
Takeda Pharmaceutical Company Limited |
Active agent delivery systems and methods for protecting and administering active agents
|
US20040044038A1
(en)
*
|
2002-06-10 |
2004-03-04 |
Barnaba Krochmal |
Polymorphic form XVI of fexofenadine hydrochloride
|
WO2004054955A1
(fr)
*
|
2002-12-16 |
2004-07-01 |
Ranbaxy Laboratories Limited |
Procede de preparation de la fexofenadine
|
EP1592662A1
(fr)
*
|
2003-01-31 |
2005-11-09 |
Ranbaxy Laboratories Limited |
Procede de preparation de fexofenadine
|
US20050026890A1
(en)
*
|
2003-07-31 |
2005-02-03 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an antihistamine for treatment of asthma or chronic obstructive pulmonary disease
|
US20050065183A1
(en)
*
|
2003-07-31 |
2005-03-24 |
Indranil Nandi |
Fexofenadine composition and process for preparing
|
GB0319935D0
(en)
*
|
2003-08-26 |
2003-09-24 |
Cipla Ltd |
Polymorphs
|
TW200517114A
(en)
|
2003-10-15 |
2005-06-01 |
Combinatorx Inc |
Methods and reagents for the treatment of immunoinflammatory disorders
|
WO2005102999A2
(fr)
*
|
2004-04-26 |
2005-11-03 |
Teva Pharmaceutical Industries Ltd. |
Formes cristallines d'hydrochlorure de fexofenadine, et procedes pour les preparer
|
WO2006008567A1
(fr)
*
|
2004-06-18 |
2006-01-26 |
Wockhardt Limited |
Compositions pharmaceutiques a base de composes piperidinoalcanols
|
ITMI20041568A1
(it)
*
|
2004-07-30 |
2004-10-30 |
Dipharma Spa |
"polimorfi di fexofenadina base"
|
US7498443B2
(en)
*
|
2004-09-17 |
2009-03-03 |
Albany Molecular Research, Inc. |
Process for production of carebastine
|
US7498345B2
(en)
*
|
2004-09-17 |
2009-03-03 |
Albany Molecular Research, Inc. |
Process for production of piperidine derivatives
|
US20060148851A1
(en)
*
|
2004-09-28 |
2006-07-06 |
Shlomit Wizel |
Fexofenadine crystal form and processes for its preparation thereof
|
US8758816B2
(en)
*
|
2004-11-24 |
2014-06-24 |
Meda Pharmaceuticals Inc. |
Compositions comprising azelastine and methods of use thereof
|
DK2377557T3
(en)
|
2004-11-24 |
2017-02-06 |
Meda Pharmaceuticals Inc |
Compositions comprising azelastine and methods for its use
|
US20070020330A1
(en)
|
2004-11-24 |
2007-01-25 |
Medpointe Healthcare Inc. |
Compositions comprising azelastine and methods of use thereof
|
JP2008120684A
(ja)
*
|
2005-03-07 |
2008-05-29 |
Kumamoto Univ |
抗アレルギー薬
|
US20080274196A1
(en)
*
|
2005-08-05 |
2008-11-06 |
Lipin Limited |
Oral Pharmaceutical Suspension Compositions Of Fexofenadine
|
US20070088065A1
(en)
*
|
2005-10-14 |
2007-04-19 |
Jie Du |
Metaxalone products, method of manufacture, and method of use
|
US20080292584A1
(en)
*
|
2005-10-14 |
2008-11-27 |
Mutual Pharmaceutical Company, Inc. |
Metaxalone products, method of manufacture, and method of use
|
WO2007049303A2
(fr)
*
|
2005-10-28 |
2007-05-03 |
Ind-Swift Laboratories Limited |
Procede ameliore pour preparer de la fexofenadine a purete elevee
|
AU2006311577B2
(en)
|
2005-11-09 |
2013-02-07 |
Zalicus Inc. |
Methods, compositions, and kits for the treatment of medical conditions
|
DOP2006000274A
(es)
*
|
2005-12-14 |
2007-10-15 |
Sanofi Aventis Us Llc |
Formulación de suspensión de fexofenadina
|
CN100443470C
(zh)
*
|
2006-07-21 |
2008-12-17 |
杭州保灵有限公司 |
一种依巴斯汀的制备方法
|
ITMI20061492A1
(it)
*
|
2006-07-27 |
2008-01-28 |
Archimica Srl |
Processo per la preparazione di fexofenadina.
|
ITMI20061491A1
(it)
*
|
2006-07-27 |
2008-01-28 |
Archimica Srl |
Processo per la preparazione di fexofenadina.
|
US20080161324A1
(en)
*
|
2006-09-14 |
2008-07-03 |
Johansen Lisa M |
Compositions and methods for treatment of viral diseases
|
BRPI0810897A2
(pt)
|
2007-04-13 |
2016-07-26 |
Southern Res Inst |
método de inibição ou redução da angiogênese, do crescimento ou metástase de tumor dependente da mesma e de tratamento de doença ou desordem associada a angiogênese.
|
ITMI20070987A1
(it)
*
|
2007-05-16 |
2008-11-17 |
Dipharma Francis Srl |
Procedimento per la preparazione di composti chetonici
|
US20090076080A1
(en)
*
|
2007-09-19 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched fexofenadine
|
US20090306135A1
(en)
|
2008-03-24 |
2009-12-10 |
Mukesh Kumar Sharma |
Stable amorphous fexofenadine hydrochloride
|
WO2009145921A1
(fr)
*
|
2008-05-30 |
2009-12-03 |
Fairfield Clinical Trials, Llc |
Procédé et composition pour une inflammation et une décoloration de la peau
|
US20100092479A1
(en)
*
|
2008-08-18 |
2010-04-15 |
Combinatorx (Singapore) Pte. Ltd. |
Compositions and methods for treatment of viral diseases
|
CN101585805B
(zh)
*
|
2009-06-06 |
2011-07-06 |
浙江大学宁波理工学院 |
一种抗过敏药物非索非那定盐酸盐的制备方法
|
EP2289867A3
(fr)
|
2009-08-19 |
2012-04-25 |
Jubilant Organosys Limited |
Procédé de production d'acide acétique 4-(4-halo-1-oxybutyl)-alpha, alpha-dimethylbenzene ou esthers d'alkyle associés
|
CN101671292B
(zh)
*
|
2009-10-10 |
2011-09-07 |
浙江大学宁波理工学院 |
盐酸非索非那定的合成方法
|
US20110130711A1
(en)
*
|
2009-11-19 |
2011-06-02 |
Follica, Inc. |
Hair growth treatment
|
EP2371817A1
(fr)
*
|
2010-04-01 |
2011-10-05 |
Arevipharma GmbH |
Procédé pour la préparation de 1-[4-(1,1-diméthyléthyl)phényl]-4-[4-(diphénylméthoxy)-1-pipéridinyl]-1-butanone et de sels d'addition acides correspondant
|
ES2403130B1
(es)
|
2010-06-15 |
2014-09-29 |
Chemelectiva S.R.L. |
Forma polimórfica de clorhidrato de fexofenadina, compuestos intermedios y procedimiento para su preparación
|
SG194625A1
(en)
|
2011-05-23 |
2013-12-30 |
Sanofi Sa |
Process for the preparation of deuterated compounds containing n-alkyl groups
|
TW201318624A
(zh)
|
2011-09-29 |
2013-05-16 |
Shionogi & Co |
包含pgd2拮抗劑及組織胺拮抗劑之過敏性鼻炎治療用醫藥
|
EP2578570A1
(fr)
|
2011-10-07 |
2013-04-10 |
Almirall, S.A. |
Nouveau procédé de fabrication de 5-(2-{[6-(2,2-difluoro-2-phényléthoxy)hexyl]amino}-1-hydroxyéthyl)-8-hydroxyquinolin-2(1h)-one via de nouveaux intermédiaires de synthèse
|
EP2641900A1
(fr)
|
2012-03-20 |
2013-09-25 |
Almirall, S.A. |
Nouvelles formes polymorphes de héminapadisylate de 5-(2-{[6-(2,2-difluoro-2-phényléthoxy) hexyl]amino}-1-(R)-hydroxyéthyl)-8-hydroxyquinolin-2(1h)-one en tant qu'agoniste du récepteur adrénergique ß2
|
CN102659667B
(zh)
*
|
2012-04-20 |
2013-08-14 |
浙江启明药业有限公司 |
一种非索非那定关键中间体的合成方法
|
CN103333100B
(zh)
*
|
2013-06-06 |
2016-04-06 |
池州东升药业有限公司 |
一种盐酸非索非那定的合成工艺
|
ITMI20131652A1
(it)
|
2013-10-07 |
2015-04-08 |
Dipharma Francis Srl |
Procedimento per la purificazione di derivati dell'acido 2-fenil-2-metil-propanoico
|
CN104557671B
(zh)
*
|
2013-10-10 |
2018-04-13 |
池州东升药业有限公司 |
一种非索非那定及中间体的合成方法
|
EP2949321A1
(fr)
|
2014-05-26 |
2015-12-02 |
Sanovel Ilac Sanayi ve Ticaret A.S. |
Formulations multicouche de fexofénadine et de montélukast
|
PT3247699T
(pt)
|
2015-01-22 |
2019-08-06 |
Sanofi Aventis Deutschland |
Processo para a produção de 2-[4-(ciclopropanocarbonil)fenil]-2-metil-propanonitrilo
|
DK3365327T3
(da)
|
2015-10-22 |
2020-02-24 |
Sanofi Aventis Deutschland |
Fremgangsmåde til fremstilling af fexofenadin og mellemprodukter, der anvendes deri
|
GB202212656D0
(en)
|
2022-08-31 |
2022-10-12 |
Novumgen Ltd |
An orodispersible tablet of fecofenadine and it process of preparation
|
WO2024153354A1
(fr)
|
2023-01-20 |
2024-07-25 |
Opella Healthcare Group Sas |
Formulations de fexofénadine sans parabène
|